OCT 12, 2017 9:00 AM PDT

Circulating Tumor Cells: Clinical Utility, Challenges, and Future Prospects

Speaker
  • Director, Department of Laboratory Medicine, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center

Abstract

The detection of CTCs has been used as useful biomarkers in prognosis and monitoring therapeutic response of patients with metastatic cancer. However, during the course of cancer therapy, CTCs have undergone epithelial-mesenchymal transition (EMT) (i.e., EMT CTCs) and the current FDA-approved technology is unable to detect such EMT CTCs. Using new technologies such as antibody against cell-surface vimentin (CSV) exclusively expressed on EMT CTCs, we are able to detect EMT CTCs from breast, colon, and prostate tumor types and monitor disease progression and predict the prognosis. This presentation will briefly review the current status of CTC detection, the detection technology and clinical utility of CTC. The challenges of the current technology and new technology in determination of CTC will be addressed. The detection of EMT CTCs especially CTC with molecular profiling for cancer diagnosis, monitoring therapeutic responses, predicting prognosis, and guiding personalized therapy will be discussed. Detection of CTCs and molecular characterization as one of the liquid biopsy approach may serve as an instrumental role for noninvasive approach in personalized cancer medicine. 


Show Resources
You May Also Like
DEC 02, 2020 8:00 AM PST
C.E. CREDITS
DEC 02, 2020 8:00 AM PST
DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
NOV 18, 2020 8:00 AM PST
C.E. CREDITS
NOV 18, 2020 8:00 AM PST
DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
OCT 08, 2020 7:00 AM PDT
C.E. CREDITS
OCT 08, 2020 7:00 AM PDT
DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
APR 01, 2021 8:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
APR 01, 2021 8:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
SEP 10, 2020 9:00 AM PDT
C.E. CREDITS
SEP 10, 2020 9:00 AM PDT
Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
OCT 29, 2020 6:00 AM PDT
C.E. CREDITS
OCT 29, 2020 6:00 AM PDT
Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
OCT 12, 2017 9:00 AM PDT

Circulating Tumor Cells: Clinical Utility, Challenges, and Future Prospects


Specialty

Immunology

Biomarkers

Personalized Medicine

Cancer

Molecular Biology

Research

Clinical Diagnostics

Research And Development

Bioinformatics

Protein

Tumor

Cell Culture

Drug Development

Biotechnology

Disease

Geography

Europe57%

North America29%

Africa14%

Registration Source

Website Visitors100%

Job Title

Research Scientist50%

Student33%

Medical Laboratory Technician17%

Organization

Academic Institution43%

Biotech Company14%

Hospital14%

Government14%

Research Institute14%


Show Resources
Loading Comments...
Show Resources
Attendees
  • See more